The global hematology market is experiencing a shift from manual testing to semi-automated analyzers to fully automated instruments. Hematology instruments have evolved rapidly over the past few years and several conventional tools were replaced by automated instruments which enable fast and accurate results. The new breakthroughs in areas such as genetic therapies, stem cell research, proteomics, pharmacogenomics, and hemoglobinopathies are also providing a significant momentum to the market.
Over the coming years, emerging countries in Asia Pacific and Latin America are expected to outperform developed nations such as the U.S. and Western European countries. The increasing healthcare spending of the people in emerging nations, rising government support, and growing awareness are some of the key factors responsible for the remarkable growth of these regions.
QYResearchReports.com contains a large depository offering a plethora of reports on niche markets under the category of hematology. Some of the markets discussed under this category are global hematology analyzers market, global automated immunohematology analyzer market, fully automated hematology analyzers market, and global hematology reagents market.